Biomarker Data in Melanoma Presented at ASCO 2018 Are Largely Extensions of Previous Studies Rather Than New Discoveries

Sanjiv S. Agarwala, MD

Video Categories: 2018 ASCO Insights, Biomarkers, and Video Library

Dr Sanjiv Agarwala argues that much of the biomarker data in melanoma presented at ASCO 2018 are around the value of PD-L1 testing; however, even PD-L1–negative melanoma patients seem to respond to anti–PD-1 therapy, although some studies suggest PD-L1–negative patients may be better candidates for combination immunotherapy.

September 20, 2013

Value of Personalized Medicine Specialty Medicines

Grant Lawless provides an overview of the value of personalized medicine in specialty medicines and primary care settings

October 14, 2014

System Burdens of Polycythemia Vera

Listen as Dr. Michaelis discusses the unique aspects of the system burdens of polycythemia vera, the difficult approach to treat and the options to treat.Supported through funding from Incyte